Cargando…
MAP4K4: an emerging therapeutic target in cancer
The serine/threonine kinase MAP4K4 is a member of the Ste20p (sterile 20 protein) family. MAP4K4 was initially discovered in 1995 as a key kinase in the mating pathway in Saccharomyces cerevisiae and was later found to be involved in many aspects of cell functions and many biological and pathologica...
Autores principales: | Gao, Xuan, Gao, Chenxi, Liu, Guoxiang, Hu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084373/ https://www.ncbi.nlm.nih.gov/pubmed/27800153 http://dx.doi.org/10.1186/s13578-016-0121-7 |
Ejemplares similares
-
MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance
por: Gao, Xuan, et al.
Publicado: (2017) -
Editorial: Diverse roles of MAP4K4 in MAP kinase signaling and its implication for cancer therapeutics
por: Roy, Ruchi, et al.
Publicado: (2023) -
BRD4: An emerging prospective therapeutic target in glioma
por: Yang, Hua, et al.
Publicado: (2021) -
ApoE4: an emerging therapeutic target for Alzheimer’s disease
por: Safieh, Mirna, et al.
Publicado: (2019) -
TMPRSS4: an emerging potential therapeutic target in cancer
por: de Aberasturi, A L, et al.
Publicado: (2015)